Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cam-h2 (1 trial)
131i-sgmib anti-her2 vhh1 (1 trial)
Breast Neoplasms (Phase 1)
Disease Progression (Phase 2)
Trials (2 total)
Trial APIs (2 total)